Role of Self-focused Attention in Depression

NCT05464550•Centre Hospitalier Henri Laborit

Summary

Using a task measuring the tracking of eye movements, the aim of this study is to demonstrate that individuals suffering from depression focus their attention more on their reflection in the screen after recalling a failure (and this all the more so as their depressive symptomatology is strong) .

Eligibility

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•patients with depressive disorders according to the Diagnostic and statistical Manual of Mental Disorders (DSM-V) criteria
•Men or women, aged 18 to 60
•patients without mental impairment
•patients without neurological impairment (epilepsy, encephalopathy, head trauma)
•patients with a sufficient command of French
•free patients, without guardianship or curators or subordination
•patients benefiting from coverage by a social security scheme or benefiting from it through a third party in accordance with the French law on biomedical research
•obtaining oral non-objection by the patient after clear and honest information about the study
•Patient with normal or corrected vision without rigid contact lenses

Exclusion Criteria

•patients with an intelligence quotient \< 70
•patients aged \< 18 years or \> 60 years
•patients with mental impairment
•patients with neurological impairment (epilepsy, encephalopathy, head trauma)
•patients who do not speak French well enough
•patients hospitalized under duress
•patients without social security
•Patient wearing rigid contact lenses

Locations (1)

Centre Hospitalier Henri Laborit

Poitiers, France

Key Dates

Start Date

December 8, 2021

Primary Completion Date

June 15, 2022

Completion Date

June 16, 2022

Last Updated

May 24, 2023

Enrollment

ACTUAL participants

Conditions

Depression

Interventions

Eye tracker

BEHAVIORAL

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 24, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Role of Self-focused Attention in Depression

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures